StarCapital Multi Income A

Reference Data

ISIN LU0256567925
Valor Number 2584613
Bloomberg Global ID
Fund Name StarCapital Multi Income A
Fund Provider IPConcept (Luxemburg) S.A. Zürich, Switzerland
Phone: +352 260248-1
E-Mail: info.lu@ipconcept.com
Web: www.ipconcept.com
Fund Provider IPConcept (Luxemburg) S.A.
Representative in Switzerland IPConcept (Schweiz) AG
Zürich
Phone: +41 044 224 32 09
Distributor(s)
Asset Class Bonds
EFC Category Multi-Asset Eurozone Defensive EUR
Distribution Policy Distribution
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 164.88 EUR 14.08.2025
Previous Price * 164.50 EUR 13.08.2025
52 Week High * 166.51 EUR 19.02.2025
52 Week Low * 154.46 EUR 16.08.2024
NAV * 164.88 EUR 14.08.2025
Issue Price * 169.83 EUR 14.08.2025
Redemption Price * 164.88 EUR 14.08.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 78,492,125
Unit/Share Assets *** 70,009,338
Trading Information SIX

Performance

YTD Performance +2.66% 30.12.2024
14.08.2025
YTD Performance (in CHF) +2.83% 30.12.2024
14.08.2025
1 month +1.45% 14.07.2025
14.08.2025
3 months +1.50% 14.05.2025
14.08.2025
6 months -0.81% 14.02.2025
14.08.2025
1 year +6.97% 14.08.2024
14.08.2025
2 years +15.58% 14.08.2023
14.08.2025
3 years +11.17% 16.08.2022
14.08.2025
5 years +0.15% 14.08.2020
14.08.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Xetra-Gold 7.28%
Bellevue Option Premium I 4.34%
United States Treasury Notes 3.5% 2.15%
Braskem Netherlands Finance B V 4.5% 1.51%
iShares Core S&P 500 ETF USD Acc 1.51%
Xtrackers Euro Stoxx 50 ETF 1C 1.49%
E.ON SE 3.88% 1.30%
Meta Platforms Inc Class A 1.30%
Palantir Technologies Inc Ordinary Shares - Class A 1.29%
Teva Pharmaceutical Finance Netherlands II B.V 3.75% 1.28%
Last data update 30.04.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.90%
Ongoing Charges *** 1.41%
SRRI ***
SRRI date *** 31.07.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)